Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
News
Last Orders: Small caps snap three-day winning streak
Health & Biotech
Volpara shares gain on $23m acquisition of breast-cancer risk assessment company
Experts
ScoPo’s powerplays: Market hit by profit-taking, but healthcare outperforms
News
Last Orders: What you might have missed on the ASX today
Guides
Brainchip leads the ASX’s top small cap AI stocks in 2020
Health & Biotech
Volpara Health shares dip as losses, revenue grows
News
Last Orders: What you might have missed on the ASX today
Experts
ScoPo’s health powerplays: ‘We said October was going to be volatile’
Experts
ScoPo’s Powerplays: Healthcare companies raised $1bn year-to-date
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
SomnoMed taps tech for new board hires, posts full-year profit
Experts
Scopo’s powerplays: Strap yourselves in for some M&A
Health & Biotech
Digital health a goldmine for investors
Experts
Scopo’s health powerplays: The cash caboose keeps rolling on
Experts
Scopo’s health powerplays: Markets are getting back to normal
Health & Biotech
